ES2045945T3 - Forma de dosificacion para suministrar farmacos solubles o insolubles. - Google Patents

Forma de dosificacion para suministrar farmacos solubles o insolubles.

Info

Publication number
ES2045945T3
ES2045945T3 ES90914278T ES90914278T ES2045945T3 ES 2045945 T3 ES2045945 T3 ES 2045945T3 ES 90914278 T ES90914278 T ES 90914278T ES 90914278 T ES90914278 T ES 90914278T ES 2045945 T3 ES2045945 T3 ES 2045945T3
Authority
ES
Spain
Prior art keywords
dosage form
pharmaces
insoluble
soluble
supply soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90914278T
Other languages
English (en)
Inventor
Atul Devdatt Ayer
Anthony L Kuczynski
Patrick S L Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ES2045945T3 publication Critical patent/ES2045945T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)

Abstract

SE DESCRIBE UNA FORMA DE DOSIS QUE COMPRENDE MEDIOS GRANULADOS PARA LA ADMINISTRACION DE MEDICAMENTOS SOLUBLES O INDISOLUBLES A UN ANIMAL DE SANGRE CALIENTE.
ES90914278T 1989-09-05 1990-08-31 Forma de dosificacion para suministrar farmacos solubles o insolubles. Expired - Lifetime ES2045945T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/403,523 US5035897A (en) 1989-09-05 1989-09-05 Dosage form for delivering soluble or insoluble drugs

Publications (1)

Publication Number Publication Date
ES2045945T3 true ES2045945T3 (es) 1994-01-16

Family

ID=23596097

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90914278T Expired - Lifetime ES2045945T3 (es) 1989-09-05 1990-08-31 Forma de dosificacion para suministrar farmacos solubles o insolubles.

Country Status (19)

Country Link
US (1) US5035897A (es)
EP (1) EP0490987B1 (es)
JP (1) JP2840446B2 (es)
KR (1) KR920703022A (es)
AT (1) ATE96309T1 (es)
AU (1) AU629053B2 (es)
CA (1) CA2024505C (es)
DE (1) DE69004265T2 (es)
DK (1) DK0490987T3 (es)
ES (1) ES2045945T3 (es)
FI (1) FI920957A0 (es)
GR (1) GR1001017B (es)
IE (1) IE62595B1 (es)
MX (1) MX164443B (es)
NO (1) NO920785L (es)
NZ (1) NZ235126A (es)
PT (1) PT95168B (es)
WO (1) WO1991003235A1 (es)
ZA (1) ZA906973B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2089738C (en) * 1990-09-28 1997-01-21 Avinash Govind Thombre Dispensing device containing a hydrophobic medium
AU3136293A (en) * 1991-11-15 1993-06-15 Isp Investments Inc. Pharmaceutical tablet with pvp having an enhanced drug dissolution rate
US5480651A (en) * 1992-03-16 1996-01-02 Regents Of The University Of California Composition and method for treating nicotine craving in smoking cessation
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
US5595752A (en) * 1994-07-01 1997-01-21 Monsanto Company Increasing dressing percentage and carcass weight in finishing beef cattle
US5672357A (en) * 1994-07-01 1997-09-30 Monsanto Company Method and device for implantation of large diameter objects in bovines
US6004582A (en) * 1997-05-30 1999-12-21 Laboratorios Phoenix U.S.A, Inc. Multi-layered osmotic device
US6706283B1 (en) * 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
ATE433318T1 (de) * 1999-02-10 2009-06-15 Pfizer Prod Inc Osmotisches system zur verabreichung von wirkstoffen, die feste amorphe dispersionen enthalten
PT1242055E (pt) * 1999-12-23 2008-07-02 Pfizer Prod Inc Forma de dosagem de fármaco baseada em hidrogel
BR0016555A (pt) 1999-12-23 2002-09-17 Pfizer Prod Inc Composições farmacêuticas que proporcionam concentrações acrescidas de droga
MXPA02006335A (es) 1999-12-23 2002-12-13 Pfizer Prod Inc Forma de dosificacion de farmaco en capas impulsada por hidrogel.
US7704528B2 (en) * 2003-05-05 2010-04-27 Isp Investments Inc. Binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability
US8778395B2 (en) 2005-08-11 2014-07-15 Andrx Labs, Llc Diltiazem controlled release formulation and method of manufacture
US11911513B2 (en) 2018-05-23 2024-02-27 Shanghai Wd Pharmaceutical Co., Ltd Controlled-release system of active pharmaceutical ingredient and preparation method therefor
WO2019223753A1 (zh) * 2018-05-23 2019-11-28 上海汉都医药科技有限公司 活性药物成分的控释系统及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US2798053A (en) * 1952-09-03 1957-07-02 Goodrich Co B F Carboxylic polymers
US2909462A (en) * 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
US3173876A (en) * 1960-05-27 1965-03-16 John C Zobrist Cleaning methods and compositions
NL271831A (es) * 1960-11-29
US3276586A (en) * 1963-08-30 1966-10-04 Rosaen Filter Co Indicating means for fluid filters
US3546142A (en) * 1967-01-19 1970-12-08 Amicon Corp Polyelectrolyte structures
US3541006A (en) * 1968-07-03 1970-11-17 Amicon Corp Ultrafiltration process
US3541005A (en) * 1969-02-05 1970-11-17 Amicon Corp Continuous ultrafiltration of macromolecular solutions
US3865108A (en) * 1971-05-17 1975-02-11 Ortho Pharma Corp Expandable drug delivery device
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4002173A (en) * 1974-07-23 1977-01-11 International Paper Company Diester crosslinked polyglucan hydrogels and reticulated sponges thereof
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4207893A (en) * 1977-08-29 1980-06-17 Alza Corporation Device using hydrophilic polymer for delivering drug to biological environment
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4320759A (en) * 1980-04-28 1982-03-23 Alza Corporation Dispenser with diffuser
US4309996A (en) * 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4434153A (en) * 1982-03-22 1984-02-28 Alza Corporation Drug delivery system comprising a reservoir containing a plurality of tiny pills
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
CH668187A5 (de) * 1986-08-07 1988-12-15 Ciba Geigy Ag Therapeutisches system mit systemischer wirkung.
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery

Also Published As

Publication number Publication date
GR900100658A (en) 1992-01-20
FI920957A7 (fi) 1992-03-04
NO920785D0 (no) 1992-02-28
DE69004265T2 (de) 1994-02-24
AU6429990A (en) 1991-04-08
DE69004265D1 (de) 1993-12-02
KR920703022A (ko) 1992-12-17
JP2840446B2 (ja) 1998-12-24
JPH05500223A (ja) 1993-01-21
ZA906973B (en) 1991-06-26
ATE96309T1 (de) 1993-11-15
DK0490987T3 (da) 1993-11-29
US5035897A (en) 1991-07-30
PT95168B (pt) 1997-06-30
AU629053B2 (en) 1992-09-24
MX164443B (es) 1992-08-13
EP0490987B1 (en) 1993-10-27
NO920785L (no) 1992-03-02
WO1991003235A1 (en) 1991-03-21
GR1001017B (el) 1993-03-31
PT95168A (pt) 1991-05-22
FI920957A0 (fi) 1992-03-04
NZ235126A (en) 1993-03-26
CA2024505C (en) 2000-06-27
IE903167A1 (en) 1991-03-13
CA2024505A1 (en) 1991-03-06
IE62595B1 (en) 1995-02-08
EP0490987A1 (en) 1992-06-24

Similar Documents

Publication Publication Date Title
ES2045945T3 (es) Forma de dosificacion para suministrar farmacos solubles o insolubles.
ES2067231T3 (es) Formas de dosificado para suministrar un agente antiparkinson.
PT95169A (pt) Forma de dosagem para administracao de glipizida hipoglicemica por via oral
IT1104643B (it) Sistema terapeutico in forma di cerotto o simile per la somministrazione di clonidina per via transdermica e procedimento per la sua preparazione
ES2037385T3 (es) Un procedimiento de manufactura de una preparacion farmaceutica para administracion local.
NL990001I2 (nl) Geneesmiddel, dat dipyridamol of modipamol en O-acetylsailcylzuur resp. fysiologisch verdraagbare zouten daarvan, bevat, werkwijze voor de bereiding daarvan en toepassing daarvan voor het bestrijden van thrombusvorming.
ES513357A0 (es) "un sistema terapeutico bajo la forma de un vendaje para administrar el medicamento".
IT8047726A0 (it) Catetere per la somministrazione endovenosa intermittente di medicamenti
ATE96308T1 (de) Dosierform fuer verabreichung in der humanmedizin.
ES2033682T3 (es) Procedimiento para preparar una composicion farmaceutica que contiene acido 2-(2-fluoro-4-bifenilil)propionico o una de sus sales.
ATE46444T1 (de) Rektale verabreichung von arzneimitteln mit hilfsmitteln.
NO883500D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan.
PT91049B (pt) Dispositivo para administracao oral de um medicamento aum animal ruminante
DK400887D0 (da) Anvendelse af 15-deoxyspergualin til fremstilling af et laegemiddel
FR2355502A1 (fr) Application a titre de medicaments d'un derive de la piperazine et de ses sels
SE8501312D0 (sv) Etoposide oral dosage form
DK162471C (da) Suge- eller tyggetablet
MX9203735A (es) Una forma de dosis mejorada para suministrar una droga o un agente terapeutico a un ambiente de uso.
FR2427822A1 (fr) Medicament pour le traitement des maladies circulatoires, a base de 5-methyl-7-dimethylamino-s-triazolo (1,5-a) pyrimidine
ES2063713B1 (es) Ampolla y solucion para infusion de acido tioctico en forma de las sales solubles en agua del acido tioctico.
ES2096081T3 (es) Utilizacion de interleuquina 10 para la preparacion de medicamentos con una actividad inhibidora de tumores.
GB1254125A (en) Pharmaceutical composition suitable for the treatment of certain vascular diseases
ATE56144T1 (de) Pharmazeutische zubereitung fuer perkutane verabreichung, die eperison oder tolperison oder eines ihrer salze enthaelt.
ATE65182T1 (de) Lithiumsalze enthaltende pharmazeutische zubereitungen.
SE8605216D0 (sv) Novel medicinal use

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 490987

Country of ref document: ES